A one-time procedure that effectively reduces the risk of stroke in patients with non-valvular atrial fibrillation.
See How It Works
We are bringing together top industry visionaries to learn, innovate and share.
Explore CVForward
Discover the latest treatments, explore practice and patient tools, and learn from industry leaders on PVPodium.
Explore PVPodium.com
That’s the difference between making devices and making progress.
Get to Know Us
Explore our breakthrough products that make a meaningful difference in patient's lives.
Discover our reimbursement resources including coding guides and our c-code lookup tool.
Learn about living with an implanted device, explore health conditions and treatment options, and get support.
Advance your career. Work at the foremost of medical innovation. And make a meaningful impact on lives around the globe.
Advance your career. Work at the foremost of medical innovation. And make a meaningful impact on lives around the globe.
We're always looking for groundbreaking ideas for new products or ways to improve existing ones.
We're always looking for groundbreaking ideas for new products or ways to improve existing ones.
Discover our commitment to doing business sustainably and responsibly in communities around the world.
Discover our commitment to doing business sustainably and responsibly in communities around the world.
Our 2017 Annual Meeting of Stockholders will take place on Tuesday, May 9, 2017.
Our 2017 Annual Meeting of Stockholders will take place on Tuesday, May 9, 2017.
Boston Scientific Receives CE Mark for Vercise™ Gevia™ Deep Brain Stimulation System
Boston Scientific Announces Positive Outcomes From Prospective Study Of Bronchial Thermoplasty
The Boston Scientific LOTUS™ Valve System Demonstrated Superior Efficacy to CoreValve® in Global REPRISE III Trial at One Year
Boston Scientific Closes Symetis Acquisition
Boston Scientific Announces Positive European Registry Results For WATCHMAN™ Left Atrial Appendage Closure Device
New Data from PLATINUM Diversity Study Presented at SCAI 2017 Provide Important Insights Beyond Traditional Clinically-Reported Endpoints
Boston Scientific S-ICD System Demonstrates Positive Clinical Outcomes in the Largest Prospective Study of 'Real-World' Patients
Boston Scientific Announces Schedule of Presentations at EuroPCR 2017
Boston Scientific Receives U.S. FDA Approval For Resonate™ Family Of High-Voltage Devices
